Validity of the Marathi version of the Hospital and Anxiety Depression Scale in cancer patients
Not Applicable
Completed
- Conditions
- Health Condition 1: null- 50 Adult cancer patients and 50 caregivers of cancer patients
- Registration Number
- CTRI/2018/03/012568
- Lead Sponsor
- Savita Goswami
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
1. Marathi speaking
2. Able to undergo psychiatric clinical interview
3. Able to give informed consent
Exclusion Criteria
1. History of pre-existing psychiatric illness including psychotic disorder
2. Cognitive impairment
3. Delirium or dementia
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary - <br/ ><br>Internal consistency by Cronbachâ??s alpha, <br/ ><br>Sensitivity, specificity, ROC <br/ ><br> <br/ ><br>Timepoint: single time point at enrollment
- Secondary Outcome Measures
Name Time Method Secondary - <br/ ><br>Factor structure (by PCA) <br/ ><br>Timepoint: single time point at enrollment
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What biomarkers correlate with anxiety/depression in cancer patients using the Marathi HADS?
How does the Marathi HADS compare to English HADS in detecting depressive symptoms in oncology settings?
What molecular pathways link cancer progression to adjustment disorders measured by the Marathi HADS?
Are there adverse psychological effects of using the Marathi HADS in cancer patient-caregiver dyads?
How does the Marathi HADS validate against other cultural adaptations of the HADS in oncology populations?